Skip to main content
SpringerLink
Log in

Immunoglobulin (IVIG) Infusion Therapy

  • Chapter
  • First Online:
Infusion Therapy

  • 630 Accesses

Abstract

Immune globulin is a blood product that has uses for treating a range of disorders including autoimmune, immunodeficiency, and inflammatory states. Continuing research suggests that it may also have utility in treating chronic pain associated with complex regional pain syndrome, diabetic and idiopathic lumbosacral radiculoplexus neuropathy, Sjogren’s syndrome, and Fibromyalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Palabrica FR, Kwong SL, Padua FR. Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study. Asia Pac Allergy. 2013;3(4):249–56.

    Article  Google Scholar 

  2. Teeling JL, et al. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood. 2001;98(4):1095–9.

    Article  CAS  Google Scholar 

  3. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291(5503):484–6.

    Article  CAS  Google Scholar 

  4. Anthony RM, et al. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 2011;475(7354):110–3.

    Article  CAS  Google Scholar 

  5. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77–104.

    Article  CAS  Google Scholar 

  6. Thornby KA, Henneman A, Brown DA. Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches. Ann Pharmacother. 2015;49(6):715–26.

    Article  CAS  Google Scholar 

  7. Saeedian M, Randhawa I. Immunoglobulin replacement therapy: a twenty-year review and current update. Int Arch Allergy Immunol. 2014;164(2):151–66.

    Article  CAS  Google Scholar 

  8. Appropriate uses of human immunoglobulin in clinical practice: memorandum from an IUIS/WHO meeting. Bull World Health Organ. 1982;60(1):43–7.

    Google Scholar 

  9. Requirements for the collection, processing, and quality control of blood, blood components, and plasma derivatives. WHO technical Report Series 1989, No. 786, Annex 4.

    Google Scholar 

  10. Tamburin S, et al. Immunoglobulin g for the treatment of chronic pain: report of an expert workshop. Pain Med. 2014;15(7):1072–82.

    Article  Google Scholar 

  11. Bussa M, et al. Adult complex regional pain syndrome type I: a narrative review. PM R. 2017;9(7):707–19.

    Article  Google Scholar 

  12. Tamburin S, et al. Long-term response of neuropathic pain to intravenous immunoglobulin in relapsing diabetic lumbosacral radiculoplexus neuropathy. A case report. Pain Pract. 2014;14(2):E85–90.

    Article  Google Scholar 

  13. Tracy JA, Engelstad JK, Dyck PJ. Microvasculitis in diabetic lumbosacral radiculoplexus neuropathy. J Clin Neuromuscul Dis. 2009;11(1):44–8.

    Article  Google Scholar 

  14. Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med. 2009;10(8):1476–80.

    Article  Google Scholar 

  15. Morozumi S, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren’s syndrome. J Neurol Sci. 2009;279(1–2):57–61.

    Article  CAS  Google Scholar 

  16. Harden RN, et al. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8(4):326–31.

    Article  Google Scholar 

  17. Stanton-Hicks M, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63(1):127–33.

    Article  CAS  Google Scholar 

  18. Freedman M, et al. Complex regional pain syndrome: diagnosis and treatment. Phys Med Rehabil Clin N Am. 2014;25(2):291–303.

    Article  Google Scholar 

  19. Bussa M, et al. Complex regional pain syndrome type I: a comprehensive review. Acta Anaesthesiol Scand. 2015;59(6):685–97.

    Article  CAS  Google Scholar 

  20. Perez RS, et al. Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol. 2010;10:20.

    Article  Google Scholar 

  21. O’Connell NE, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. (2013, 4):CD009416.

    Google Scholar 

  22. Duong S, et al. Treatment of complex regional pain syndrome: an updated systematic review and narrative synthesis. Can J Anaesth. 2018;65(6):658–84.

    Article  Google Scholar 

  23. Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM. 2006;99(2):89–95.

    Article  CAS  Google Scholar 

  24. Birklein F, O’Neill D, Schlereth T. Complex regional pain syndrome: An optimistic perspective. Neurology. 2015;84(1):89–96.

    Article  Google Scholar 

  25. Tachdjian R. Complex regional pain syndrome treated with intravenous immunoglobulin in a patient with common variable immune deficiency. Pain Ther. 2013;2(2):129–34.

    Article  Google Scholar 

  26. Medlin F, et al. Favorable outcome of an acute complex regional pain syndrome with immunoglobulin infusions. Clin J Pain. 2013;29(11):e33–4.

    Article  Google Scholar 

  27. Goebel A, et al. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med. 2002;3(2):119–27.

    Article  Google Scholar 

  28. Goebel A, et al. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med. 2010;152(3):152–8.

    Article  Google Scholar 

  29. Goebel A, et al. Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial. Ann Intern Med. 2017;167(7):476–83.

    Article  Google Scholar 

  30. Pascoe MK, et al. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997;72(12):1123–32.

    Article  CAS  Google Scholar 

  31. Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2017;(7):CD006521.

    Google Scholar 

  32. van Eijk, J., Y.C. Chan, and J.W. Russell, Immunotherapy for idiopathic lumbosacral plexopathy. Cochrane Database Syst Rev. 2013; (12): CD009722.

    Google Scholar 

  33. Kawagashira Y, et al. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry. 2007;78(8):899–901.

    Article  CAS  Google Scholar 

  34. Kawagashira Y, et al. Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropathy types of painful diabetic neuropathy. J Clin Neurosci. 2010;17(8):1003–8.

    Article  CAS  Google Scholar 

  35. Zochodne DW, Isaac D, Jones C. Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy. Acta Neurol Scand. 2003;107(4):299–301.

    Article  CAS  Google Scholar 

  36. Park DH, Park YK, Kim JH. Intravenous immunoglobulin therapy for idiopathic postoperative lumbosacral plexopathy. J Clin Neurosci. 2005;12(3):313–5.

    Article  Google Scholar 

  37. Verma A, Bradley WG. High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy. Neurology. 1994;44(2):248–50.

    Article  CAS  Google Scholar 

  38. Triggs WJ, et al. Treatment of idiopathic lumbosacral plexopathy with intravenous immunoglobulin. Muscle Nerve. 1997;20(2):244–6.

    Article  CAS  Google Scholar 

  39. Stefanski AL, et al. The diagnosis and treatment of Sjogren’s syndrome. Dtsch Arztebl Int. 2017;114(20):354–61.

    PubMed  PubMed Central  Google Scholar 

  40. Kizawa M, et al. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogren’s syndrome. J Neurol Neurosurg Psychiatry. 2006;77(8):967–9.

    Article  CAS  Google Scholar 

  41. Wakasugi D, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren’s syndrome. Mod Rheumatol. 2009;19(4):437–40.

    Article  Google Scholar 

  42. Mori K, et al. The wide spectrum of clinical manifestations in Sjogren’s syndrome-associated neuropathy. Brain. 2005;128(Pt 11):2518–34.

    Article  Google Scholar 

  43. Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford). 2008;47(2):208–11.

    Article  CAS  Google Scholar 

  44. Perez EE, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139(3S):S1–S46.

    Article  CAS  Google Scholar 

  45. Baum S, et al. The role of IVIg treatment in severe pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2006;20(5):548–52.

    Article  CAS  Google Scholar 

  46. Prins C, Gelfand EW, French LE. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol. 2007;87(3):206–18.

    CAS  PubMed  Google Scholar 

  47. Dourmishev LA, Guleva DV, Miteva LG. Intravenous immunoglobulins: mode of action and indications in autoimmune and inflammatory dermatoses. Int J Inflam. 2016;2016:3523057.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL, USA

    Eileen Bui, Antony Tharian, Kenneth D. Candido & Nebojsa Nick Knezevic

  2. Department of Anesthesiology, University of Illinois, Chicago, IL, USA

    Antony Tharian, Kenneth D. Candido & Nebojsa Nick Knezevic

  3. Department of Surgery, University of Illinois, Chicago, IL, USA

    Kenneth D. Candido & Nebojsa Nick Knezevic

Authors
  1. Eileen Bui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antony Tharian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth D. Candido
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nebojsa Nick Knezevic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nebojsa Nick Knezevic .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Wisconsin, Madison, WI, USA

    Alaa Abd-Elsayed

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bui, E., Tharian, A., Candido, K.D., Knezevic, N.N. (2019). Immunoglobulin (IVIG) Infusion Therapy. In: Abd-Elsayed, A. (eds) Infusion Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-17478-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17478-1_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17477-4

  • Online ISBN: 978-3-030-17478-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation